Page last updated: 2024-10-26

carbonyl cyanide p-trifluoromethoxyphenylhydrazone and Cardiac Hypertrophy

carbonyl cyanide p-trifluoromethoxyphenylhydrazone has been researched along with Cardiac Hypertrophy in 1 studies

Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone: A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.
carbonyl cyanide p-trifluoromethoxyphenylhydrazone : A hydrazone that is hydrazonomalononitrile in which one of the hydrazine hydrogens is substituted by a p-trifluoromethoxyphenyl group.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Weng, X1
Liu, H1
Zhang, X1
Sun, Q1
Li, C1
Gu, M1
Xu, Y1
Li, S1
Li, W1
Du, J1

Other Studies

1 other study available for carbonyl cyanide p-trifluoromethoxyphenylhydrazone and Cardiac Hypertrophy

ArticleYear
An α
    International journal of medical sciences, 2020, Volume: 17, Issue:16

    Topics: Adrenergic alpha-2 Receptor Agonists; AMP-Activated Protein Kinases; Animals; Carbonyl Cyanide p-Tri

2020